PFIZER INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
PFIZER INC (PFE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $5.98 per share for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2020-02-27
- PFIZER INC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $5.98, a 18.18% increase from fiscal 2018.
- PFIZER INC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $5.06, a 26.18% increase from fiscal 2017.
- PFIZER INC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $4.01, a 3.08% increase from fiscal 2016.
- PFIZER INC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $3.89, a 9.53% decline from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2019-12-31 | $5.98 10-K · filed 2020-02-27 |
| 2018-12-31 | $5.06 10-K · filed 2020-02-27 |
| 2017-12-31 | $4.01 10-K · filed 2020-02-27 |
| 2016-12-31 | $3.89 10-K · filed 2019-02-28 |
| 2015-12-31 | $4.30 10-K · filed 2018-02-22 |
| 2014-12-31 | $4.40 10-K · filed 2017-02-23 |
| 2013-12-31 | $3.13 10-K · filed 2016-02-29 |
| 2012-12-31 | $2.79 10-K · filed 2015-02-27 |
| 2010-12-31 | $3.25 10-K · filed 2011-02-28 |
| 2009-12-31 | $3.30 10-K · filed 2011-02-28 |
| 2008-12-31 | $3.30 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |